|
 |
Myasthenie (Myasthenia gravis)
A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis- Köhler W, Bucka C, Klingel R. Journal of Clinical Apheresis, 2011.
- Langzeitbehandlung der therapierefraktären Myasthenia gravis mittels Immunadsorption
- Wagner S, Janzen RWC, Mohs C, Pohlmann S, Klingel R, Grützmacher PW. Deutsche Medizinische Wochenschrift 133: 2377-2382, 2008.
- Langzeitbehandlung der therapierefraktären Myasthenia gravis mittels therapeutischer Apherese
- Wagner S, Janzen RWC, Mohs C, Grützmacher P. Poster, Kongress für Nephrologie, München, 2007.
- Myasthenia gravis: Pathogenese und Immuntherapie
- Schneider-Gold C, Toyka KV. Deutsches Ärzteblatt 104(7): A420-A426, 2007.
- Immunoadsorption in Guillain-Barré syndrome and Myasthenia gravis
- Haupt WF, Rosenow F, van der Ven C, Birkmann C. Therapeutic Apheresis 4: 195-197, 2000.
- Therapeutic apheresis in Mysthenia gravis patients: A six year follow-up
- Schneidewind JM, Zettl UK, Winkler RE, Ramlow W, Tiess M, Hofmann D, Michelsen a, Weber G, Kinze EM, Adam U, Hauk L, Behnecke R, Klinkmann H. Therapeutic Apheresis 3: 298-302, 1999.
- Myasthenic crisis with delayed recovery after plasmapheresis
- Matsuo H, Goto H, Ohtsuru I, Izumoto H, Fukudome T, Fujishita S, Shibuya N. Therapeutic Apheresis 3: 326-328, 1999.
Guillain-Barré-Syndrom (GBS)
- Selective immune adsorption treatment of severe Guillain-Barré syndrome in the intensive care unit
- Galldiks N, Dohmen C, Neveling M, Fink GR, Haup WF. Neurocritical Care 11: 317-321, 2009.
- Monozentrische intensivmedizinische Erfahrungen mit der selektiven Immunadsorption bei schweren Verlaufsformen des Guillain-Barré-Syndroms
- Galldiks N, Neveling M, Fink GR, Haup WF. Poster, Jahrestagung der Deutschen Gesellschaft für Neurologie, Hamburg, 2008.
- Factors influencing outcome in Guillain-Barré syndrome: comparison of plasma adsorption against other treatments
- Seta T, Nagayama H, Katsura K, Hamamoto M, Araki T, Yokochi M, Utsumi K, Katayama Y. Clinical Neurology and Neurosurgery 107: 491-496, 2005.
- Recent advances of therapeutic apheresis in Guillain-Barré syndrome
- Haupt WF. Therapeutic Apheresis 4: 271-274, 2000.
- Apheresis and selective adsorption plus immunoglobulin treatment in Guillain-Barré syndrome
- Haupt WF, Birkmann C, van der Ven C, Pawlik G. Therapeutic Apheresis 4: 198-200, 2000.
- Immunoadsorption in Guillain-Barré syndrome and Myasthenia gravis
- Haupt WF, Rosenow F, van der Ven C, Birkmann C. Therapeutic Apheresis 4: 195-197, 2000.
Chronisch verlaufende, inflammatorische, demyelinisierende Polyneuritis (CIDP)
- Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment
- Galldiks N, Burghaus L, Dohmen C, Teschner S, Pollok M, Leebmann J, Frischmuth N, Hollinger P, Nazli N, Fassbender C, Klingel R, Benzing T, Fink GR, Haupt WF. European Neurology 66: 183-189, 2011.
- Chronic inflammatory demyelinating polyneuropathy
- Köller H, Kieseier BC, Jander S, Hartung HP. The New England Journal of Medicine 352: 1343-1356, 2005.
- Long term immunadsorption (IA) - save and effective outpatient treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
- Kresse S, Marx M, Holinger R, Marx C, Fassbender C, Osten B, Klingel R. Kidney Blood Pressure Research 23: 214-347, 2000 (Abstract, Poster).
Multiple Sklerose
- Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis
- Trebst C, Bronzlik P, Kielstein JT, Schmidt BMW, Stangel M. Blood Prification 33: 1-6, 2012.
- Immunadsorption bei steroidrefraktärem Schub der Multiplen Sklerose
- Mauch E, Zwanzger J, Hettich R, Fassbender C, Klingel R, Heigl F. Nervenarzt 12: 1590-1595, 2011.
- Plasmapherese in der Eskalationstherapie der Multiplen Sklerose: Verlaufsbeobachtung an 35 Patienten
- Schröder A, Fischer M, Meyer C, Ellrichmann G, Thöne J, Linker RA, Chan A, Gold R. Aktuelle Neurologie 36: 105-110, 2009.
- Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange
- Keegan M, König F, McClelland R, Brück W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF. The Lancet 366: 579-582, 2005.
- Plasma exchange for severe optic neuritis
- Ruprecht K, Klinker E, Dintelmann T, Rieckmann P, Gold R. Neurology 63: 1081-1083, 2004.
- Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system
- Weinshenker BG. Journal of Clinical Apheresis 16: 39-42, 2001.
Limbische Enzephalitis
- Autoimmune synaptische Enzephalopathien
- Friese MA, Magnus T. Nervenarzt 82: 1239-1249, 2011.
- Antikörperassoziierte Erkrankungen der grauen Substanz des ZNS - Diagnostik und Therapie
- Bien CG. Nervenarzt 82: 986-993, 2011.
Pemphigus
- Empfehlungen für die Anwendung der Immunapherese bei der Therapie bullöser Autoimmundermatosen
- Zillikens D, Derfler K, Eming R, Fierlbeck G, Goebeler M, Hertl M, Hofmann SC, Karlhofer F, Kautz O, Nitschke M, Opitz A, Quist S, Rose C, Schanz S, Schmidt E, Shimanovich I, Sticherling M, Ziller F. Journal der deutschen Dermatologischen Gesellschaft 5: 881-888, 2007.
- Immunadsorption bei schweren bullösen Autoimmundermatosen
- Eming R, Kuhlmann U, Hoyer J, Hertl M. Nephro News 8(3): 50-51, 2006.
- Successful removal of pathogenic autoantibodies in pemphigus by immunadsorption with tryptophan-linked polyvinylalcohol adsorber
- Lüftl M, Strauber A, Mainka A, Klingel R et al.. Brit J Dermatol 149: 598-605, 2003.
Rheumatoide Arthritis
- Immunoadsorption with tryptophan columns: a therapeutic option for the treatment of rheumatoid arthritis with septic complications
- Thomaidis T, Schorn C, Flaig W, Lingg G, Schönhals E, Klingel R, Galle PR, Schwarting A. Journal of Clinical Apheresis 24: 37-41, 2009.
- Immunoadsorption for the treatment of rheumatoid arthritis: Final results of a randomized trial
- Furst D, Felson D, Thoren G, Gendreau RM for the Prosorba Trial Investigators. Therapeutic Apheresis 4: 363-373, 2000.
- Immunoadsorbent plasma perfusion in patients with rheumatoid arthritis or systemic Lupus erythematosus
- Yamazaki Z, Fujimori Y, Iizoka I, Kanai F, Takahama T, Wada T, Asano K, Yoshizawa H, Takahashi Y, Ogita T, Inoue N, Yamawaki N, Inagaki K, Tsuda N in: Progress in Artificial Organs - 1983, Atsumi K et al. eds., ISAO Press, Cleveland: 708-712, 1984.
- Treatment of SLE and RA with new immunoadsorbent
- Tsuruta Y, Maeda K, Shinzato T, Yoshida F, Usuda M, Sezaki R, Yamada K, Toyoda T, Ohbayashi S, Narita M, Yamawaki N, Furuta T, Inagaki K in: Therapeutic Plasmapheresis (III), Oda T ed., F.K. Schattauer Verlag, Stuttgart: 241-245, 1983.
Weitere Indikationen der Immunadsorption
- Therapeutische Apherese in der Neurologie - Plädoyer für die Immunadsorption
- Klingel R, Fassbender C, Heibges A. Spektrum der Nephrologie 24: 3-12, 2011.
- Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives
- Klingel R, Heibges A, Fassbender C. Atherosclerosis Supplements 10: 129-132, 2009.
- Immunoadsorption with tryptohan adsorbers for successful treatment of late steroid-refractory recurrent focal glomerulosclerosis
- Beige J, Perrez-Canto A, Moosmayer I, Offermann G, Zidek W, Klingel R. American Jouernal of Transplantation 3: 1459, 2003.
- Immunoadsorption with tryptophane-linked polyvinylalcohol adsorber in patients with dilated cardiomyopathy
- Müller J, Bieda H, Kurz S et al.. Kidney Blood Pressure Research: 23: 214-347, 2000 (Abstract, Poster).
- Treatment of FSGS with plasma exchange and immunoadsorption
- Franke D, Zimmering M, Wolfish N et al.. Pedriatr Nephrol 14: 965-969, 2000.
